baber/WOPTO huggingface dataset:
Patent AU-2004211972-B2 (AU)
Title: Method, apparatus and article for evaluating card games, such as blackjack
Inventor: MOUCHOU ROBERT B
IPC: A63F1/00
Filed: 2004-02-09
Granted: 2010-06-17
Abstract: Identifiers are read from playing cards collected after completion of at least one hand of a card game, such as blackjack, and the value of a hand is determined from the resulting sequence of read identifiers (i.e., ending sequence). The playing cards are collected in a defined order, such as from players in order from a dealer's right to left, and finally from the dealer. The cards, and the play of the game, can be validated based at least in part on the ending sequence. Identifiers may also be read from cards before or while dealing the card game to produce an initial sequence.
Patent AU-2004213740-B2 (AU)
Title: Floorboard and method of manufacturing thereof
Inventor: PERVAN DARKO
IPC: E04F15/02
Filed: 2004-02-24
Granted: 2010-01-21
Abstract: Floorboards with a surface of flexible fibers for laying a mechanically joined floating floor. The invention further comprises methods for manufacturing and providing floorings containing such floorboards.
Patent AU-2004298488-B2 (AU)
Title: Shaving systems
Inventor: AVIZA GREGORY D
IPC: B26B21/40
Filed: 2004-12-08
Granted: 2009-09-10
Abstract: A wet-shaving system can include an exfoliation member, the position of which is adjustable relative to a housing and/or handle portion of the wet-shaving system.
Patent AU-2004325988-B2 (AU)
Title: Dairy ingredient - preparation and use
Inventor: ANEMA SKELTE GERALD
IPC: A23J3/08
Filed: 2004-12-24
Granted: 2012-01-19
Abstract: The invention provides a method for producing a dairy powder or a dairy concentrate. The pH of a liquid dairy starting material comprising casein and whey proteins is adjusted if necessary by addition of acid or alkali to a pH in the range 5.0-8.0. The pH adjusted material is then heat-treated to denature whey protein in the presence of casein. This treated material is either retained or dried to form a powder or as a dairy concentrate. The product may be used in a method for forming a product such as a processed cheese, a processed cheese-like product, a spread, a yoghurt or a dairy dessert. In this method, the product is dissolved/suspended (if necessary) and undergoes pH adjustment to a pH in the range 4.5-6.5. The material may be cooked to form a molten mass which is subsequently cooled to form a milk protein gel.
Patent AU-2005230545-B2 (AU)
Title: Transparent and polarizing vision element having areas which are associated with polarization filters that are respectively vertically and horizontally oriented
Inventor: MUISENER RICHARD
IPC: G02C7/12
Filed: 2005-03-29
Granted: 2011-01-20
Abstract: A transparent and polarizing vision element (2) divided into several areas. At least two of said areas are associated with a luminous polarization filter. The light flowing through the element is allocated differently for two the areas according to a direction of polarization of the light. At least one polarization filter is oriented vertically, and at least one polarization filter is oriented horizontally in relation to the usual position of the element.
Patent AU-2005284908-B2 (AU)
Title: Biosynchronous transdermal drug delivery
Inventor: GUY DIPIERRO
IPC: A61N1/30
Filed: 2005-09-13
Granted: 2011-12-08
Abstract: A delivery mechanism and device for the passive periodic release of a drug or an active ingredient and the methods for synchronizing the administration of compounds with the human body's natural circadian rhythms and addiction rhythms. This strategy is intended to counteract disease states and symptoms when they are likely to be at their worst by using an automated and pre-programmable transdermal or other drug administration system.
Patent AU-2005295919-B2 (AU)
Title: Platelet-derived growth factor compositions and methods of use thereof
Inventor: LYNCH SAMUEL E
IPC: C07K14/00
Filed: 2005-10-12
Granted: 2009-03-26
Abstract: A method for promoting growth of bone, periodontium, ligament, or cartilage in a mammal by applying to the bone, periodontium, ligament, or cartilage a composition comprising platelet-derived growth factor at a concentration in the range of about 0.1 mg/mL to about 1.0 mg/mL in a pharmaceutically acceptable liquid carrier and a pharmaceutically-acceptable solid carrier.
Patent AU-2005302452-B2 (AU)
Title: Methods and compositions for reducing neurodegeneration in Amyotrophic Lateral Sclerosis
Inventor: YOO SEO HONG
IPC: A61P25/28
Filed: 2005-10-31
Granted: 2010-12-09
Abstract: A composition comprising a clear aqueous solution comprising: 
(a) a first material selected from soluble ursodeoxycholic acid or a sodium salt oftauroursodeoxycholic acid (TUDCA); 
(b) a carbohydrate selected from the group consisting of an aqueous soluble starch conversion product or an aqueous soluble non-starch polysaccharide; 
(c) water, wherein the first material and the carbohydrate both remain in solution for any subset of the range of pH values obtainable in an aqueous system sufficient for a pharmaceutical formulation to remain in solution from preparation, to administration, to absorption in the body;  
for use in the treatment of at least one symptom of a neurodegenerative disease or at least one symptom of a motor neuron disease in a subject.
Patent AU-2005325135-B2 (AU)
Title: Frame for an orthopedic brace including offset hinges
Inventor: MASON BRADLEY R
IPC: A61F5/00
Filed: 2005-12-29
Granted: 2011-08-04
Abstract: A frame is provided for an orthopedic brace having a frame assembly and an opposing frame assembly. The frame assembly includes a first longitudinal support and a second longitudinal support rotatably connected by a rotational hinge. The opposing frame assembly includes a first opposing longitudinal support and a second opposing longitudinal support rotatably connected by an opposing rotational hinge. The first longitudinal support has a greater degree of flexibility than the first opposing longitudinal support and/or the second longitudinal support has a greater degree of flexibility than the second opposing longitudinal support to enhance the fit of the frame with the body of a user.
Patent AU-2005330699-B2 (AU)
Title: Personal care compositions comprising silicone resins with enhanced properties, method of manufacture, and method of use thereof
Inventor: KUO AN-LI
IPC: A61K8/891
Filed: 2005-06-01
Granted: 2012-08-09
Abstract: A personal care composition comprising a silicone resin of the generic formula: MQ, wherein the ratio of M to Q is about from 0.01/1 to about 3.96/1; MDT, wherein x is about 0.01 to about 3,900,000, y is about 0.035 to about 10,000,000, z is about 0.35 to about 8,000,000; TD, wherein the ratio of T to D is about 0.001/1 to about 73/1; or a combination comprising at least one of the foregoing resins, wherein the resin or resin combination is present in an amount effective to increase the SPF of the formulation at least about 10% over the same formulation without the resin or resin combination. The silicone resins are easily formulated, provide a unique non-tacky sensory experience and exhibit advantageous spreadability while permitting the introduction of additional functional benefits such as homogeneity, better organic compatibility, reduced skin irritation and improved skin feel or shine.
Patent AU-2006200864-B2 (AU)
Title: TNF-alpha production inhibitors
Inventor: HORIUCHI MASATO
IPC: A61K31/4439
Filed: 2006-02-28
Granted: 2007-12-06
Abstract: A purpose of the present invention is to provide TNF-± production inhibitors being useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis. Novel compounds having the structure represented by the general formula [1] or salts thereof according to the present invention have excellent TNF-± production inhibitory activities,   
wherein "A" is -(NR 4 )-, or -O-, "B" is alkylene or alkenylene, R 1 , R 2  and R 4  are hydrogen, alkyl, alkenyl, adamantyl or the like, R 3  is a pyridine ring, and "X" is oxygen or sulfer respectively.
Patent AU-2006216514-B2 (AU)
Title: Compositions and their uses directed to IL-4R alpha
Inventor: GREGORY SUSAN
IPC: A61P11/00
Filed: 2006-02-24
Granted: 2012-02-16
Abstract: Disclosed herein are compounds, compositions and methods for modulating the expression of IL- 4R alpha in a cell, tissue or animal. Also provided are methods of target validation. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders related to expression of IL 4R-α, airway hyperresponsiveness, and/or pulmonary inflammation.
Patent AU-2006225170-B2 (AU)
Title: Separator tool for a modular prosthesis
Inventor: JONES MICHAEL C
IPC: A61F2/46
Filed: 2006-09-29
Granted: 2012-05-10
Abstract: A tool for separating components of a modular prosthesis includes an upper and lower body, each defining opposing bills at one end that are sized to fit in juxtaposed relation within an initial gap between the components. The upper body is 5 provided with a handle so that the tool may be manually held by the surgeon with the opposing bills in position in the prosthesis. The tool includes a jack assembly disposed between the upper and lower bodies of the tool that is configured to be driven into an extended position, gradually separating the upper and lower bodies, and consequently exerting a separation force on the prosthesis components through 10 the bills of the tool. The jack assembly is driven by a threaded actuator rod that bears against one element of the jack assembly as the actuator rod is rotated within a threaded bore in one of the bodies of the tool. 28/09/06,16052 specification,2 12. Lb Z3 2a 15 FIG. 1 FIG. 2
Patent AU-2006226390-B2 (AU)
Title: Benzamidine derivatives for treatment and prevention of cancer therapy induced mucositis
Inventor: ARTUSI ROBERTO
IPC: A61K31/17
Filed: 2006-03-16
Granted: 2011-09-08
Abstract: Mucositis is the result of a complex process of interactive biologic phenomena that take place in both the epitelium and the submucosa, often leading to severe pain and increased risk of dangerous systemic infections. Mucositis is often a side effect during chemotherapy and radiation therapy. The benzamidine derivatives herein described are particularly effective for treating and preventing mucositis since they are acting simultaneously at the several phases that characterize this disease.
Patent AU-2006238975-B2 (AU)
Title: Method of migrating RFID transponders in situ
Inventor: DAVIS MICHAEL L
IPC: H04L9/00
Filed: 2006-11-21
Granted: 2011-07-07
Abstract: Methods and apparatus for updating secure access credentials are provided. More specifically, data from one or more RFID credentials can be read and subsequently 5 written to one of the original RFID credentials reducing multiple RFID credentials to a single credential. The RFID transponder on the credential that has new data written thereon does not necessarily need to have the same functionality as the RFD transponder on the other RFID credentials that was read. c'.JJ C)
Patent AU-2006252070-B2 (AU)
Title: Foamable alcoholic composition
Inventor: MARCIA SNYDER
IPC: A61K47/34
Filed: 2006-12-15
Granted: 2011-08-11
Abstract: A stable foam composition includes greater than about 40 weight percent of an alcohol, based upon the total weight of the alcoholic composition, and a foaming surfactant selected from fluorosurfactants, siloxane polymer surfactants, and combinations thereof. 5 When the foaming surfactant includes a fluorosurfactant, the alcoholic composition further includes a polymeric or oligomeric foam stabilizer.
Patent AU-2006285613-B2 (AU)
Title: Isoxazoline-substituted benzamide compound and harmful organism-controlling agent
Inventor: MANABU YAOSAKA
IPC: A01N43/80
Filed: 2006-09-01
Granted: 2011-11-17
Abstract: Disclosed is a novel harmful organism-controlling agent, particularly an insecticide or acaricide. An isoxazoline-substituted benzamide compound represented by the general formula (1) or a salt thereof; and a harmful organisms-controlling agent comprising the compound or salt: (1) wherein A, A and A independently represent a carbon or nitrogen atom; G represents a benzene ring or the like; W represents an oxygen or sulfur atom; X represents a halogen atom, a C-C haloalkyl group or the like; Y represents a halogen atom, a C-Calkyl group or the like; R represents -CH=NOR, -C(O)OR, -C(O)NHR or a phenyl group substituted by (Z), D-14, D-52, D-53, D-55 to -59 or the like; R represents a C-Calkyl group or the like; R represents a C-Calkyl group or the like; R represents a hydrogen atom, -C(O)R, -C(O)OR or the like; R represents a C-Calkyl group, -CHR, a C-Calkynyl group, -C(O)R, -C(O)OR or the like, provided that R may represent a hydrogen atom when R represents -CH=NOR, -C(O)OR or -C(O)NHR; R represents a C-Chaloalkyl group or the like; R represents a cyano group, -OR or the like; R represents a C-C alkyl group, a C-C haloalkyl group, a C-C alkoxy(C-C)alkyl group, a C-C alkylthio(C-C)alkyl group, a C-C cycloalkoxy group, a C-C alkenyl group or the like; R represents a C-C alkyl group, a C-C haloalkyl group, -C(O)R, -C(O)OR or the like; R represents a C-C alkyl group, a C-C cycloalkyl group or the like; Z represents a halogen atom, a cyano group, a nitro group, a C-C alkyl group, a C-C alkoxy group or the like; m is an integer of 0 to 5; n is an integer of 0 to 4; and p1 is an integer of 1 to 5.
Patent AU-2006293798-B2 (AU)
Title: Composition comprising a NSAID and paracetamol
Inventor: SHERRY ROBERT
IPC: A61K31/67
Filed: 2006-09-07
Granted: 2012-08-16
Abstract: A process for producing a granular composition comprising a plurality of solidified melt granules including a non-steroidal anti-inflammatory drug (NSAID) and paracetamol, the process comprising the steps of: (a) forming a melt mixture by mixing a molten NSAID free acid and paracetamol, optionally with one or more excipients; and (b) forming the melt mixture into solidified melt granules.
Patent AU-2006294481-B2 (AU)
Title: Detection of lysophosphatidylcholine for prognosis or diagnosis of a systemic inflammatory condition
Inventor: GENTLE THOMAS
IPC: A61K31/66
Filed: 2006-09-27
Granted: 2012-12-20
Abstract: The present invention provides methods and compositions useful for the diagnosis or prognosis of a systemic inflammatory condition such as sepsis.
Patent AU-2006304290-B2 (AU)
Title: Amino acid, carbohydrate and acrylamide polymers useful as flocculants in agricultural and industrial settings
Inventor: DANIEL SIKES T
IPC: C09K8/58
Filed: 2006-10-12
Granted: 2011-06-30
Abstract: Modified polysaccharides, acrylamide copolymers, water-soluble amino acid copolymers, and combinations thereof are described for uses including flocculation of solids, particularly flocculation of soil in an agricultural settings and clarification of process waters from oil-sands mining operations. Also described are methods of preparing selected amino acid copolymers and modified polysaccharides.
Patent AU-2007230747-B2 (AU)
Title: Novel hybrid intraocular lens materials for small incision surgery
Inventor: MAKKER HARISH C
IPC: C08G77/20
Filed: 2007-03-15
Granted: 2012-11-29
Abstract: Intraocular lenses comprised of an acrylic-silicone hybrid polymer are disclosed. The intraocular lenses described herein are suitable for insertion through incisions of 2 mm or less.
Patent AU-2007240126-B2 (AU)
Title: A heat engine/heat pump
Inventor: BARTON NOEL GEOFFREY
IPC: F01B29/12
Filed: 2007-04-18
Granted: 2012-03-01
Abstract: A heat engine (1) which includes an inlet duct (5) to receive an air stream containing hot dry air; a turbine (15) operatively associated with the inlet duct (5). The turbine (15) in use extracts energy from an inlet air stream as the air stream flows into the inlet duct (5). An evaporator (20) extends from an outlet end of the inlet duct (5) and is operable to evaporate water injected into the air stream. There are means (25) to inject water droplets into the air stream. An outlet duct (35) extends from the evaporator (20). A fan (30) at an outlet end of the outlet duct (35) is operable to extract air from the evaporator (20).
Patent AU-2007251904-B2 (AU)
Title: Jointing System for Pipe Lining
Inventor: GREEN RONALD WILLIAM
IPC: F16L57/00
Filed: 2007-12-20
Granted: 2012-11-08
Abstract: - 15 Abstract A jointing system for lining on concrete structures comprising: edge linings for internally lining the ends of 5 adjacent concrete elements to be jointed together to form a structure, the edge linings being continuous with main lining on the structure, wherein the edge linings have anchoring means to anchor the edge linings to the element ends, and having interlocking means; and 10 a cover strip for bridging the edge linings on adjacent elements and having a second interlocking means capable of coupling with the first interlocking means to create a joint between the pipes N:\Mclboume\Cascs\Patent\71000-71999\P71050.AU.l\Specis\P7105O.AU.I Specification 2007-12-17.dcc 19/12107 (~jN) 4' *11 K) C)',
Patent AU-2007313388-B2 (AU)
Title: Heating an organic-rich rock formation in situ to produce products with improved properties
Inventor: MEURER WILLIAM P
IPC: C10G9/02
Filed: 2007-10-10
Granted: 2013-01-31
Abstract: A method of producing hydrocarbon fluids with improved hydrocarbon compound properties from a subsurface organic-rich rock formation, such as an oil shale formation, is provided. The method may include the step of heating the organic- rich rock formation in situ. In accordance with the method, the heating of the organic-rich rock formation may pyrolyze at least a portion of the formation hydrocarbons, for example kerogen, to create hydrocarbon fluids. Thereafter, the hydrocarbon fluids may be produced from the formation. Hydrocarbon fluids with improved hydrocarbon compound properties are also provided.
Patent AU-2007317730-B2 (AU)
Title: Methods of treating neuronal disorders using MNTF peptides and analogs thereof
Inventor: KO PUI-YUK DOROTHY
IPC: A01N61/00
Filed: 2007-11-13
Granted: 2014-01-09
Abstract: The present disclosure relates to methods for treating neuronal disorders using a motoneuronotrophic factor (MNTF) or its peptide analogs. The present disclosure further relates to methods for treating a spinal cord injury, a neurodegenerative disease, a stroke or cerebral ischemia, Huntington's Disease, Parkinson's Disease, Multiple Sclerosis, amyotrophic lateral sclerosis (ALS), Alzheimer's Disease, and diabetic neuropathy in a subject by administration of motoneuronotrophic factor (MNTF) or its peptide analogs.
Patent AU-2007328247-B2 (AU)
Title: Method and apparatus of enabling multi band transmission
Inventor: ZUNIGA JUAN CARLOS
IPC: H04W56/00
Filed: 2007-12-04
Granted: 2012-02-23
Abstract: A method and apparatus for enabling multi-band transmission includes transmitting a beacon on a first radio band and transmitting the beacon on a second radio band. The beacon includes coordination information for transmission on the first and second radio bands.
Patent AU-2007343750-B2 (AU)
Title: More efficient ether modifiers for copper extractant formulations
Inventor: VIRNIG MICHAEL
IPC: B01D15/04
Filed: 2007-12-03
Granted: 2012-04-26
Abstract: The disclosed invention provides water-insoluble, water-immiscible extraction reagent compositions comprising an extractant reagent comprising one or more aldoxime extractants, optionally including one or more ketoxime extractants, in combination with one or more ether or polyether equilibrium modifiers, or mixtures thereof, selected from the compounds of Formula I-III.
Patent AU-2008271665-B2 (AU)
Title: Method for the production of a component, and component
Inventor: WOLFRAM GEIGER
IPC: B81B7/00
Filed: 2008-03-28
Granted: 2011-12-01
Abstract: The invention relates to a method for producing a component (2), especially a micromechanical, micro-electro-mechanical, or micro-opto-electro-mechanical component (2), as well as such a component (2) which has an active structure (27) that is embedded in a layer structure. In order to be able to better contact electrodes (5) of the active structure (27), strip conductor bridges (34) are formed by etching first and second depressions (14, 15) having a first and second, different etching depth (D1, D2) into a covering layer (13) of a first layer combination (10) that additionally encompasses a substrate (11) and an insulation layer (12). The deeper depression (14) is used for insulating the strip conductor bridge (34) while the shallower depression (15) provides a moving space for the active structure (27), said moving space being bridged by the strip conductor bridge (34).
Patent AU-2008287484-B2 (AU)
Title: Pressure balanced engine valves
Inventor: SCUDERI STEPHEN P
IPC: F01L9/16
Filed: 2008-07-17
Granted: 2011-07-28
Abstract: A split-cycle engine includes a crankshaft rotatable about a crankshaft axis. A compression piston is slidably received within a compression cylinder and operatively connected to the crankshaft such that the compression piston reciprocates through intake and compression strokes during a single rotation of the crankshaft. An expansion piston is slidably received within an expansion cylinder and operatively connected to the crankshaft such that the expansion piston reciprocates through expansion and exhaust strokes during a single rotation of the crankshaft. A crossover passage interconnects the expansion and compression cylinders. The crossover passage includes crossover compression (XovrC) and crossover expansion (XovrE) valves defining a pressure chamber therebetween. At least one of the XovrC and XovrE valves is a balanced valve. A fluid pressure balancer biases the valve for balancing fluid pressures acting against the valve in both opening and closing directions, reducing the forces required in actuating the valve.
Patent AU-2008312468-B2 (AU)
Title: AXMI-066 and AXMI-076: delta-endotoxin proteins and methods for their use
Inventor: AGARWAL SHRUTI
IPC: C07K14/325
Filed: 2008-10-16
Granted: 2014-07-31
Abstract: Compositions and methods for conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions comprising a coding sequence for pesticidal polypeptides are provided. The coding sequences can be used in DNA constructs or expression cassettes for transformation and expression in plants and bacteria. Compositions also comprise transformed bacteria, plants, plant cells, tissues, and seeds. In particular, isolated pesticidal nucleic acid molecules are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed. In particular, the present invention provides for isolated nucleic acid molecules comprising nucleotide sequences encoding the amino acid sequence shown in SEQ ID NO:5, 2, or 10, the nucleotide sequence set forth in SEQ ID NO:4, 1, 3, 4, 6, 9, or 11, or the nucleotide sequence deposited in a bacterial host as Accession No. B-50045, as well as variants and fragments thereof.
Patent AU-2008319334-B2 (AU)
Title: Solid catalyst system for biodiesel production
Inventor: DULEBOHN JOEL I
IPC: C07C67/03
Filed: 2008-10-30
Granted: 2012-04-26
Abstract: The invention provides efficient, inexpensive, and environmental friendly catalysts and catalyst systems. The catalysts can be used to catalyze esterification and/or transesterification reactions, for example, for the preparation of biodiesel. Kiln dust, such as cement kiln dust (CKD) or lime kiln dust (LKD) can be used to convert a variety of feedstock acids and/or esters to biodiesel in high yield under mild conditions. The CKD and LKD catalyst systems are recyclable esterification or transesterification catalysts that can be used to prepare biodiesel, such as methyl soyate, from various feedstocks, including vegetable oils and animal fats.
Patent AU-2008338971-B2 (AU)
Title: Processes for the preparation of normorphinan salts
Inventor: BAO JIAN
IPC: C07D489/08
Filed: 2008-12-17
Granted: 2013-08-29
Abstract: The invention provides a process for the conversion of opioid derivatives into normorphinan compounds useful for making 'nal' compound analgesics and antagonists. In particular, the process may be used for the production of pure normorphinan salts from crude opioid substrates.